25.08 05:57 | dpa-AFX: Weekly Biotech Buzz: AADI Trims R&D Jobs, JNJ Loosens Purse Strings, FDA Snubs REGN's Myeloma Drug |
23.08 14:52 | dpa-AFX: Janssen-Cilag's Balversa Gets EC Approval For Metastatic Urothelial Carcinoma |
23.08 13:35 | dpa-AFX: *JANSSEN-CILAG INTERNATIONAL: EC APPROVES BALVERSA FOR UNRESECTABLE OR METASTATIC UROTHELIAL CARCINOMA IN ADULTS |
20.08 14:09 | dpa-AFX: Johnson & Johnson To Acquire V-Wave For Initial Payment Of $600 Mln |
20.08 13:51 | dpa-AFX: Johnson & Johnson's Chemotherapy-free Lung Cancer Treatment Rybrevant Plus Lazcluze Gets FDA Nod |
20.08 13:38 | dpa-AFX: *JOHNSON & JOHNSON EXPECTS V-WAVE TRANSACTION TO DILUTE ADJ. EPS BY $0.24 IN 2024 AND $0.06 IN 2025 |
20.08 13:37 | dpa-AFX: *JOHNSON & JOHNSON - V-WAVE DEAL EXPECTED TO CLOSE BEFORE END OF 2024 |
20.08 13:35 | dpa-AFX: *JOHNSON & JOHNSON TO ACQUIRE V-WAVE FOR $600 MLN UPFRONT, WITH POTENTIAL FOR $1.1 BLN IN MILESTONE PAYMENTS |
20.08 13:05 | dpa-AFX: *JOHNSON & JOHNSON:FDA APPROVES RYBREVANT+LAZCLUZE FOR 1ST-LINE TREATMENT OF ADULTS WITH EGFR-MUTATED LUNG CANCER |
16.08 12:28 | MARKT USA/Wall Street nach Rally behauptet erwartet |
16.08 10:31 | US-Regierung/Pharmakonzerne einigen sich auf niedrigere Medikamentenpreise |
31.07 05:34 | dpa-AFX: Johnson & Johnson : FDA Approves Darzalex Faspro Combination For Multiple Myeloma |
26.07 15:55 | dpa-AFX: J&J: CHMP Recommends RYBREVANT With Chemo To Treat Advanced EGFR-mutated NSCLC |
26.07 14:47 | dpa-AFX: *CHMP RECOMMENDS J&J'S RYBREVANT WITH CHEMO FOR ADVANCED EGFR-MUTATED NSCLC |
26.07 14:19 | dpa-AFX: Johnson & Johnson's Yuvanci Gets Positive CHMP Opinion In Europe For Pulmonary Arterial Hypertension |
26.07 13:52 | dpa-AFX: *JOHNSON & JOHNSON GETS POSITIVE CHMP OPINION FOR YUVANCI IN PULMONARY ARTERIAL HYPERTENSION |
22.07 14:18 | dpa-AFX: Johnson & Johnson Seeks FDA Approval For SPRAVATO Nasal Spray For Treatment-Resistant Depression |
22.07 14:02 | dpa-AFX: *JOHNSON & JOHNSON SEEKS FDA APPROVAL OF SPRAVATO AS ONLY MONOTHERAPY FOR ADULTS WITH TREATMENT-RESISTANT DEPRESSION |
17.07 22:36 | MÄRKTE USA/Drohende neue Handelsbeschränkungen belasten Chipsektor |
17.07 22:12 | MÄRKTE USA/Drohende neue Handelsbeschränkungen belasten Chipsektor |
|